![Overview of resins manufacturing site in Muskegon, MI. [Cytiva]](https://www.genengnews.com/wp-content/uploads/2025/06/Muskegon_SiteOverview_May2025-1024x576.jpg)
Overview of resins manufacturing site in Muskegon, MI. [Cytiva]
Officials at Cytiva report that the company has completed significant expansion projects in several locations in the U.S., Europe, and Asia as part of its ongoing commitment to customers developing and manufacturing advanced therapeutics. Set to continue through 2028, these expansions will meet increased customer demand as part of Cytiva’s long-term growth plan and in-region manufacturing strategy, supported by an investment of $1.6 billion since 2019, says a company spokesperson.
Customers now benefit from faster delivery across Cytiva’s portfolio, including chromatography resins, filtration, single-use bags, and cell culture media, points out Pierre-Alain Ruffieux, Cytiva’s COO.
Latest investments in chromatography resins and filtration
“A robust supply chain is critical to our customers so they can deliver life-changing therapies to patients around the world,” he continues. “We have increased our global manufacturing capacity, with a focus on in-region for-region, to meet the demands and best serve the customer.”
According to the company, the latest investments in chromatography resins and filtration include:
- Approximately double production capacity of chromatography resins manufacturing in Uppsala, Sweden with the addition of new factories, new equipment, as well as improved automation capabilities and a new tank farm for solvent storage.
- Investment in chromatography resins reserves in Sweden to support customers with short-term emergency needs.
- Enhanced local supply in North America with the construction of a second resins manufacturing site with approximately 100 full-time associates in Muskegon, MI, now. The site is slated to be fully operational with plans to hire about 100 more associates by end of 2028.
- New filtration manufacturing lines in Pensacola, FL which will increase the site’s production capacity for filter membranes for North America by 20% by August 2025, with its most-ordered products stocked on-the-shelf.
- Upgrades and expansions in filtration manufacturing Fajardo, Puerto Rico, improving capacity by 33%.
- Expanded filtration device manufacturing in lfracombe, U.K., improving capacity by 81%.
- The start of filtration manufacturing at Cytiva’s Innovation Hub and manufacturing facility in South Korea in 2026 to address increased demand for high-quality filtration solutions in Asia-Pacific.
The company also notes that its latest capacity investments are also expanding “in-region, for region” manufacturing of single-use bags, which enable customers to change batches during their processes. Specific developments include the trebling of single-use consumable manufacturing capacity in Beijing, China, doubling of manufacturing capacity in Duncan, SC, and sustained manufacturing capacity in Medemblik, Netherlands.
Cytiva also is increasing access to cell culture media in North America is by expanding dry powder and liquid media manufacturing capacity in Logan, UT, for large volumes and adding high-speed bottle filling for small volumes. An expanded staging area for finished goods and a new centralized 10,000-square-foot quality control laboratory are already reportedly supporting increased manufacturing, with 73,850-square-feet of further expansions to come through 2026.
